Venture Certified
| 벤처투자유형 | 2026-01-21 ~ 2029-01-20 | 20260121010001 | 2026-01-21 |
Revenue CAGR +7.6%
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 0.2B | 0.2B | 0.0B |
| Operating Profit | -5.7B | -4.7B | -1.0B |
| Net Profit | -5.7B | -4.7B | -1.0B |
| Total Assets | 7.3B | 3.4B | 5.3B |
| Total Liabilities | 8.5B | 0.1B | 0.8B |
| Total Equity | -1.2B | 3.2B | 4.5B |
Capital Erosion: Total equity is negative or below 50% of capital stock
Operating Loss: Op. profit -6B
3 Consecutive Years of Net Loss
▲ 115.3%
▼ 102.2%
▼ 14.3%
▼ 6314.0%
▲ 655.6%
| Name | Position | Role |
|---|---|---|
| 송명석 | 대표이사 | 대표 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
1 Additional Data Sources
{
"address": "경기 성남시",
"ceo_name": "송명석",
"certificate": [
{
"cert_number": "20260121010001",
"changes": "",
"disclosure_date": "2026-01-21",
"first_cert_date": "2026-01-21",
"no": "1",
"type": "벤처투자유형",
"valid_period": "2026-01-21 ~ 2029-01-20"
}
],
"company_name": "(주)알엑스바이오",
"corp_no": "131111-*******",
"financials": {
"2022": {
"capital_stock": 556610000,
"cost_of_sales": 0,
"current_assets": 517648000,
"current_liabilities": 82159000,
"gross_profit": 0,
"net_income": -101439000,
"net_income_bs": -101439000,
"non_current_assets": 10300000,
"non_current_liabilities": 0,
"non_operating_expenses": 0,
"non_operating_income": 29000,
"operating_profit": -101468000,
"revenue": 0,
"sga_expenses": 101468000,
"total_assets": 527948000,
"total_equity": 445789000,
"total_liabilities": 82159000
},
"2023": {
"capital_stock": 906610000,
"cost_of_sales": 16962000,
"current_assets": 307947000,
"current_liabilities": 12516000,
"gross_profit": 1823000,
"net_income": -466836000,
"net_income_bs": -466836000,
"non_current_assets": 28408000,
"non_current_liabilities": 0,
"non_operating_expenses": 3042000,
"non_operating_income": 3568000,
"operating_profit": -467362000,
"revenue": 18785000,
"sga_expenses": 469185000,
"total_assets": 336354000,
"total_equity": 323839000,
"total_liabilities": 12516000
},
"2024": {
"capital_stock": 1031610000,
"cost_of_sales": 18468000,
"current_assets": 709179000,
"current_liabilities": 48629000,
"gross_profit": 1752000,
"net_income": -568049000,
"net_income_bs": -568049000,
"non_current_assets": 16942000,
"non_current_liabilities": 800000000,
"non_operating_expenses": 0,
"non_operating_income": 6945000,
"operating_profit": -574994000,
"revenue": 20220000,
"sga_expenses": 576746000,
"total_assets": 726121000,
"total_equity": -122509000,
"total_liabilities": 848629000
}
},
"industry": "의학 및 약학 연구개발업",
"investment": [
{
"amount": "500,000,000",
"changes": "500,000,000",
"date": "2025-12-23"
}
],
"main_products": "의학,약학 연구개발/애완용동물 관련용품 도소매",
"phone": "010-8860-****",
"years": [
2024,
2023,
2022
]
}Data Quality: 8/10 | Primary Source: Venture System | Section Coverage: 7/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | Public Data | Collected |
| Financial Statements | Venture System | Collected |
| Investment Metrics | Venture System | Collected |
| Officers | Public Data | Collected |
| Employment | Not Collected | Not Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| G2B Procurement | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Venture System Detail | 2026-02-25 | Collected |